1058083--2/17/2010--IMS_HEALTH

related topics

{acquisition, growth, future}

{regulation, government, change}

{system, service, information}

{property, intellectual, protect}

{financial, litigation, operation}

{product, market, service}

{competitive, industry, competition}

{regulation, change, law}

{operation, international, foreign}

{personnel, key, retain}

{operation, natural, condition}

{stock, price, share}

Our data suppliers might restrict our use of or refuse to license data, which could lead to our inability to provide certain products or services. Laws restricting the use of information may restrict our product and service offerings. Data protection and privacy laws may restrict our current and future activities. Hardware and software failures, delays in the operation of our computer and communications systems or the failure to implement system enhancements may harm our business. Consolidation in the industries in which our clients operate may reduce the volume of products and services purchased by consolidated clients following an acquisition or merger, leading to decreased earnings. Our business is subject to exchange rate fluctuations and our revenue, net income and financial position may suffer due to currency translations. Our international operations present risks to our current businesses that could impede growth in the future. We may be unsuccessful in identifying acquisition candidates or evaluating the material risks involved in any acquisition. We may be unsuccessful in integrating any acquired operations with our existing business. Changes in tax laws or their application may adversely affect our reported results. We are involved in tax related matters that could have a material effect on us. We are, and may become, involved in litigation that could harm the value of our business. Significant technological changes could render our products and services obsolete. We may not be able to develop the technology necessary for our business, or to do so efficiently Government imposed price restrictions on pharmaceutical companies could reduce demand for our products and services. The success of our business will largely depend on the performance of the pharmaceutical and healthcare industries. Our success will depend on our ability to protect our intellectual property rights. If we are unable to attract, retain and motivate employees, we will not be able to compete effectively and will not be able to expand our business. Our businesses are subject to significant or potential competition that is likely to intensify in the future. Disruptions in commerce could adversely affect our business. The Merger is subject to satisfaction or waiver of certain customary conditions. The Merger may not be completed if sufficient financing is not funded. Our future business and financial position may be adversely affected if the Merger is not completed. Failure to complete the Merger could adversely affect our stock price.

Full 10-K form ▸

1058083--2/17/2010--IMS_HEALTH_INC